| Primary |
| Atrial Fibrillation |
12.5% |
| Cardiac Disorder |
12.5% |
| Cardiac Failure |
12.5% |
| Cerebrovascular Accident Prophylaxis |
12.5% |
| Diarrhoea |
12.5% |
| Fluid Retention |
12.5% |
| Hypertension |
12.5% |
| Pulmonary Oedema |
12.5% |
|
|
| Secondary |
| Drug Use For Unknown Indication |
26.0% |
| Product Used For Unknown Indication |
19.7% |
| Hypertension |
11.7% |
| Cardiac Failure |
8.7% |
| Suicide Attempt |
4.8% |
| Cardiac Failure Chronic |
4.2% |
| Atrial Fibrillation |
2.8% |
| Type 2 Diabetes Mellitus |
2.6% |
| Oedema |
2.4% |
| Bacterial Infection |
2.0% |
| Chylothorax |
1.8% |
| Pulmonary Arterial Hypertension |
1.8% |
| Hyperuricaemia |
1.6% |
| Ill-defined Disorder |
1.6% |
| Immunosuppression |
1.6% |
| Blood Pressure |
1.4% |
| Cardiac Failure Congestive |
1.4% |
| Renal Transplant |
1.4% |
| Chemotherapy |
1.2% |
| Hypothyroidism |
1.2% |
|
| Renal Failure Acute |
13.6% |
| Completed Suicide |
9.1% |
| Poisoning |
8.0% |
| Death |
6.8% |
| Oedema Peripheral |
5.7% |
| Vitamin B1 Deficiency |
5.7% |
| Colitis Collagenous |
4.5% |
| Pyrexia |
4.5% |
| Urine Output Decreased |
4.5% |
| Vomiting |
4.5% |
| Weight Increased |
4.5% |
| Dehydration |
3.4% |
| Haemorrhage |
3.4% |
| Hyponatraemia |
3.4% |
| Pulmonary Oedema |
3.4% |
| Renal Failure |
3.4% |
| Sleep Apnoea Syndrome |
3.4% |
| Weight Decreased |
3.4% |
| Ascites |
2.3% |
| Blood Glucose Increased |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.6% |
| Hypertension |
21.4% |
| Type 2 Diabetes Mellitus |
8.4% |
| Drug Use For Unknown Indication |
7.5% |
| Diabetes Mellitus |
5.4% |
| Pulmonary Arterial Hypertension |
3.6% |
| Atrial Fibrillation |
2.8% |
| Osteoporosis |
2.6% |
| Pain |
2.1% |
| Depression |
2.0% |
| Cardiac Failure |
1.8% |
| Prophylaxis |
1.4% |
| Multiple Myeloma |
1.3% |
| Pulmonary Hypertension |
1.3% |
| Arteriosclerosis |
1.2% |
| Dyslipidaemia |
1.2% |
| Smoking Cessation Therapy |
1.2% |
| Rheumatoid Arthritis |
1.1% |
| Cardiac Disorder |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
|
| Weight Decreased |
10.3% |
| Renal Failure |
8.6% |
| Vomiting |
8.6% |
| Weight Increased |
7.7% |
| Death |
7.5% |
| Renal Failure Acute |
6.2% |
| Hypertension |
4.5% |
| Oedema Peripheral |
4.0% |
| Pneumonia |
4.0% |
| Dyspnoea |
3.8% |
| Nausea |
3.8% |
| Cardiac Failure |
3.7% |
| Pain |
3.7% |
| Syncope |
3.7% |
| Hypotension |
3.6% |
| Pyrexia |
3.6% |
| Urine Albumin/creatinine Ratio Increased |
3.3% |
| Drug Ineffective |
3.2% |
| Somnolence |
3.2% |
| Hyponatraemia |
3.0% |
|
| Interacting |
| Pulmonary Arterial Hypertension |
54.5% |
| Bipolar Disorder |
18.2% |
| Bladder Disorder |
9.1% |
| Pollakiuria |
9.1% |
| Prophylaxis |
9.1% |
|
| Cold Sweat |
20.0% |
| Haematemesis |
20.0% |
| Hyponatraemia |
20.0% |
| Red Blood Cell Count Decreased |
20.0% |
| Tachycardia |
20.0% |
|
